These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15219188)

  • 41. Laboratory detection of antiphospholipid antibodies.
    Kandiah DA; Krilis SA
    Lupus; 1996 Apr; 5(2):160-2. PubMed ID: 8743133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
    Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
    Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The antiphospholipid syndrome in 2012: its heterogeneity requires personalized care].
    Costedoat-Chalumeau N; Saadoun D; Piette JC
    Rev Med Interne; 2012 Apr; 33(4):173-5. PubMed ID: 22336432
    [No Abstract]   [Full Text] [Related]  

  • 44. Antiphospholipid syndrome: state of the art with emphasis on laboratory evaluation.
    Greaves M
    Haemostasis; 2000; 30 Suppl 2():16-25. PubMed ID: 11251337
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cofactors involved in the antiphospholipid syndrome.
    Bevers EM; Galli M
    Lupus; 1992 Feb; 1(2):51-3. PubMed ID: 1301964
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of an enzyme-linked immunosorbent assay for antibodies to beta 2-glycoprotein I and a conventional anticardiolipin immunoassay.
    Roubey RA; Maldonado MA; Byrd SN
    Arthritis Rheum; 1996 Sep; 39(9):1606-7. PubMed ID: 8814073
    [No Abstract]   [Full Text] [Related]  

  • 47. Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India.
    Ahluwalia J; Sreedharanunni S; Kumar N; Masih J; Bose SK; Varma N; Varma S; Singh S
    Int J Rheum Dis; 2016 Sep; 19(9):903-12. PubMed ID: 25292011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical significance of antiphospholipid antibody in diagnosis of collagen diseases].
    Atsumi T
    Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2138-43. PubMed ID: 18044147
    [No Abstract]   [Full Text] [Related]  

  • 49. The importance of measuring anticardiolipin antibodies.
    de Groot PG; Derksen RH
    J Thromb Haemost; 2006 Jan; 4(1):41-3. PubMed ID: 16409446
    [No Abstract]   [Full Text] [Related]  

  • 50. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
    Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
    Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Uric acid levels in primary antiphospholipid syndrome.
    Carvalho JF; Shoenfeld Y
    Lupus; 2021 Nov; 30(13):2176-2178. PubMed ID: 34569385
    [No Abstract]   [Full Text] [Related]  

  • 52. Serum apolipoprotein H levels in systemic lupus erythematosus are not influenced by antiphospholipid antibodies.
    Ichikawa Y; Takamatsu K; Shimizu H; Uchiyama M; Moriuchi J; Takaya M; Kobayashi N; Kawada T; Arimori S
    Lupus; 1992 May; 1(3):145-9. PubMed ID: 1301975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testing for antiphospholipid antibodies: problems and solutions.
    Pierangeli SS; Gharavi AE; Harris EN
    Clin Obstet Gynecol; 2001 Mar; 44(1):48-57; quiz 58-9. PubMed ID: 11219246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiphospholipid syndrome in a patient with type I diabetes presenting as retinal artery occlusion.
    Manzanares JM; Conget I; Rodríguez-Villar C; Tassies D; Fernandez-Fernandez F; Cervera R; Levy I; Gomis R
    Diabetes Care; 1996 Jan; 19(1):92-4. PubMed ID: 8720546
    [No Abstract]   [Full Text] [Related]  

  • 55. Pulmonary events in antiphospholipid syndrome: influence of antiphospholipid antibody type and levels.
    Stojanovich L; Kontic M; Djokovic A; Ilijevski N; Stanisavljevic N; Marisavljevic D
    Scand J Rheumatol; 2012 May; 41(3):223-6. PubMed ID: 22324785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Persistent problems with standardization of immunoassays for anti-cardiolipin antibodies.
    Fontaine M; Homburger HA; Nichols WL
    Thromb Haemost; 2001 Oct; 86(4):1123-4. PubMed ID: 11686339
    [No Abstract]   [Full Text] [Related]  

  • 57. Anticardiolipin and anti-beta-2-glycoprotein I antibodies.
    Marai I; Tincani A; Balestrieri G; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):33-8. PubMed ID: 15804703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiprothrombin antibody: why do we need more assays?
    Atsumi T; Koike T
    Lupus; 2010 Apr; 19(4):436-9. PubMed ID: 20353984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiphospholipid syndromes with anti-human beta 2-glycoprotein I antibodies despite negative reactivity in conventional aPL and LA assays.
    Guérin V; Couchouron A; Vergnes C; Parrens E; Vernhes JP; Constans J; Boisseau M
    Thromb Haemost; 1997 May; 77(5):1037-8. PubMed ID: 9184427
    [No Abstract]   [Full Text] [Related]  

  • 60. Antiphospholipid syndrome: a clinical and laboratorial challenge.
    Dusse LM; Silva FD; Freitas LG; Rios DR; Armond SC; Marcolino MS
    Rev Assoc Med Bras (1992); 2014; 60(2):181-6. PubMed ID: 24919006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.